MICROBOT MEDICAL INC. Proceeds from Sale and Maturity of Marketable Securities
MICROBOT MEDICAL INC. (MBOT) reported Proceeds from Sale and Maturity of Marketable Securities of $11.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-11
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $5.25M, a 110.00% increase year-over-year.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $6.50M, a 96.91% increase year-over-year.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $1.50M, a 0.13% decline year-over-year.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $3.30M, a 2257.86% increase year-over-year.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $10.60M, a 153.52% increase from fiscal 2024.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $4.18M, a 44.26% increase from fiscal 2023.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $2.90M.
- MICROBOT MEDICAL INC. proceeds from sale and maturity of marketable securities for fiscal 2021 was $3.00M, a 18.96% increase from fiscal 2020.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $11.75M 10-Q · filed 2026-08-11 | $13.25M derived: sum of 3 quarters · filed 2026-08-11 | $16.55M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $6.50M 10-Q · filed 2026-05-13 | $8.00M derived: sum of 2 quarters · filed 2026-05-13 | $11.30M derived: sum of 3 quarters · filed 2026-05-13 | $13.80M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $4.80M derived: sum of 2 quarters · filed 2026-03-26 | $7.30M derived: sum of 3 quarters · filed 2026-08-11 | $10.60M 10-K · filed 2026-03-26 |
| 2025-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.80M derived: sum of 2 quarters · filed 2026-08-11 | $9.10M 10-Q · filed 2025-11-12 | $10.60M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $5.80M 10-Q · filed 2026-08-11 | $7.30M derived: sum of 3 quarters · filed 2026-08-11 | $7.44M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $3.30M 10-Q · filed 2026-05-13 | $4.80M derived: sum of 2 quarters · filed 2026-05-13 | $4.94M derived: sum of 3 quarters · filed 2026-05-13 | $6.13M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.64M derived: sum of 2 quarters · filed 2026-03-26 | $2.83M derived: sum of 3 quarters · filed 2026-03-26 | $4.18M 10-K · filed 2026-03-26 |
| 2024-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.33M derived: sum of 2 quarters · filed 2025-11-12 | $2.68M 10-Q · filed 2025-11-12 | $3.54M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.54M 10-Q · filed 2025-08-12 | $3.40M derived: sum of 3 quarters · filed 2025-08-12 | $4.44M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.35M 10-Q · filed 2025-05-14 | $2.21M derived: sum of 2 quarters · filed 2025-05-14 | $3.25M derived: sum of 3 quarters · filed 2025-05-14 | $3.25M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $860.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.90M derived: sum of 2 quarters · filed 2025-03-25 | $1.90M derived: sum of 3 quarters · filed 2025-03-25 | $2.90M 10-K · filed 2025-03-25 |
| 2023-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.04M derived: sum of 2 quarters · filed 2024-11-13 | $2.04M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.00M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-15 | |||
| 2021-12-31 | $3.00M 10-K · filed 2022-03-31 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $2.52M 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $2.52M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.52M 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $2.52M 10-Q · filed 2021-05-17 | |||
| 2013-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $9.87M derived: sum of 2 quarters · filed 2014-11-13 | $14.43M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $8.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $13.03M 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $4.56M 10-Q · filed 2014-05-14 | |||
| 2012-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $2.15M derived: sum of 2 quarters · filed 2013-11-05 | $5.36M 10-Q · filed 2013-11-05 | $386.00K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $3.66M 10-Q · filed 2013-08-07 | -$1.31M derived: sum of 3 quarters · filed 2014-03-13 | $3.06M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $3.21M 10-Q · filed 2013-05-10 | -$1.76M derived: sum of 2 quarters · filed 2014-03-13 | $2.61M derived: sum of 3 quarters · filed 2014-03-13 | |
| 2011-12-31 | -$4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$600.00K derived: sum of 2 quarters · filed 2014-03-13 | $158.21K 10-K · filed 2014-03-13 | |
| 2011-09-30 | $4.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $5.13M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $758.21K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |